N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide

C95H106Br4ClF7N16O16 — CID 158945624

IUPACN-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide
SMILESCC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(Br)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Cl)cc(C(F)F)c1
InChIInChI=1S/C24H26BrF3N4O4.C24H27BrF2N4O4.C24H27ClF2N4O4.C23H26Br2N4O4/c1-2-13(14-3-16(24(26,27)28)8-17(25)4-14)6-20(34)10-29-22(36)15-5-18(9-19(33)7-15)32-23-30-11-21(35)12-31-23;2*1-2-13(14-3-15(22(26)27)5-17(25)4-14)7-20(33)10-28-23(35)16-6-18(9-19(32)8-16)31-24-29-11-21(34)12-30-24;1-2-13(14-3-16(24)8-17(25)4-14)6-20(31)10-26-22(33)15-5-18(9-19(30)7-15)29-23-27-11-21(32)12-28-23/h3-5,7-9,13,21,33,35H,2,6,10-12H2,1H3,(H,29,36)(H2,30,31,32);2*3-6,8-9,13,21-22,32,34H,2,7,10-12H2,1H3,(H,28,35)(H2,29,30,31);3-5,7-9,13,21,30,32H,2,6,10-12H2,1H3,(H,26,33)(H2,27,28,29)/t4*13-/m1111/s1
InChIKeyJKUCRNAUUMGVMI-MBORSGHCSA-N
MW2216.04 g/mol
LogP14.63
Rot. Bonds34

About N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide

N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide (PubChem CID 158945624) has the molecular formula C95H106Br4ClF7N16O16 and a molecular weight of 2216.04 g/mol. Its IUPAC name is N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide.

Molecular Properties

Compound NameN-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide
PubChem CID158945624
Molecular FormulaC95H106Br4ClF7N16O16
Molecular Weight2216.04 g/mol
Exact Mass2210.43
IUPAC NameN-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide
SMILESCC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(Br)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Cl)cc(C(F)F)c1
InChIInChI=1S/C24H26BrF3N4O4.C24H27BrF2N4O4.C24H27ClF2N4O4.C23H26Br2N4O4/c1-2-13(14-3-16(24(26,27)28)8-17(25)4-14)6-20(34)10-29-22(36)15-5-18(9-19(33)7-15)32-23-30-11-21(35)12-31-23;2*1-2-13(14-3-15(22(26)27)5-17(25)4-14)7-20(33)10-28-23(35)16-6-18(9-19(32)8-16)31-24-29-11-21(34)12-30-24;1-2-13(14-3-16(24)8-17(25)4-14)6-20(31)10-26-22(33)15-5-18(9-19(30)7-15)29-23-27-11-21(32)12-28-23/h3-5,7-9,13,21,33,35H,2,6,10-12H2,1H3,(H,29,36)(H2,30,31,32);2*3-6,8-9,13,21-22,32,34H,2,7,10-12H2,1H3,(H,28,35)(H2,29,30,31);3-5,7-9,13,21,30,32H,2,6,10-12H2,1H3,(H,26,33)(H2,27,28,29)/t4*13-/m1111/s1
InChIKeyJKUCRNAUUMGVMI-MBORSGHCSA-N
XLogP14.63
TPSA492.20 Ų
H-Bond Donors20
H-Bond Acceptors28
Rotatable Bonds34
Heavy Atoms139
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002216.04
LogP ≤ 514.63
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1028

Analyze N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide?
The IUPAC name of N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide (CID 158945624) is N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide.
What is the SMILES notation for N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide?
The canonical SMILES for N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide is CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(Br)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Br)cc(C(F)F)c1.CC[C@H](CC(=O)CNC(=O)c1cc(O)cc(NC2=NCC(O)CN2)c1)c1cc(Cl)cc(C(F)F)c1.
What is the InChIKey of N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide?
The InChIKey is JKUCRNAUUMGVMI-MBORSGHCSA-N. The full InChI is InChI=1S/C24H26BrF3N4O4.C24H27BrF2N4O4.C24H27ClF2N4O4.C23H26Br2N4O4/c1-2-13(14-3-16(24(26,27)28)8-17(25)4-14)6-20(34)10-29-22(36)15-5-18(9-19(33)7-15)32-23-30-11-21(35)12-31-23;2*1-2-13(14-3-15(22(26)27)5-17(25)4-14)7-20(33)10-28-23(35)16-6-18(9-19(32)8-16)31-24-29-11-21(34)12-30-24;1-2-13(14-3-16(24)8-17(25)4-14)6-20(31)10-26-22(33)15-5-18(9-19(30)7-15)29-23-27-11-21(32)12-28-23/h3-5,7-9,13,21,33,35H,2,6,10-12H2,1H3,(H,29,36)(H2,30,31,32);2*3-6,8-9,13,21-22,32,34H,2,7,10-12H2,1H3,(H,28,35)(H2,29,30,31);3-5,7-9,13,21,30,32H,2,6,10-12H2,1H3,(H,26,33)(H2,27,28,29)/t4*13-/m1111/s1.
What are the key properties of N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide?
N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide has a molecular weight of 2216.04 g/mol, XLogP of 14.63, 34 rotatable bonds, 20 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-4-[3-bromo-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-bromo-5-(trifluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-[3-chloro-5-(difluoromethyl)phenyl]-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide;N-[(4R)-4-(3,5-dibromophenyl)-2-oxohexyl]-3-hydroxy-5-[(5-hydroxy-1,4,5,6-tetrahydropyrimidin-2-yl)amino]benzamide is sourced from PubChem (CID 158945624), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).